Updates are available Correction dated 2025-01-06
Click to view Correction: https://doi.org/10.1007/s12325-024-03087-2
-
Authors
Igarashi, Ataru
Tanaka, Shiro
De Moor, Raf
Li, Nan
Hirozane, Mariko
Wu, David Bin-Chia
Hong, Li Wen
Yu, Dae Young
Hashim, Mahmoud
Hutton, Brian
Tantakoun, Krista
Olsen, Christopher
Fashami, Fatemeh Mirzayeh
Samjoo, Imtiaz A.
Cameron, Chris https://orcid.org/0000-0003-3613-760X
-
Funding
Funding for this research was provided by:
Janssen Pharmaceutical K.K.
- License Information
-
More Information
Article History
Received: 11 July 2024
Accepted: 26 September 2024
First Online: 12 November 2024
Change Date: 6 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12325-024-03087-2
Declarations
:
: Ataru Igarashi received consulting fees from PhRMA Japan, JPMA, EFPIA Japan, Janssen, Eli Lilly Japan K.K., Shionogi & Co. Ltd., Takeda Pharmaceuticals, Novo Nordisk Japan, Eisai Japan, Medtronic Japan, Chugai Pharmaceuticals, Edwards LifeScience, GSK Japan. Ataru Igarashi received collaborative research funds from Moderna Japan Inc, Taiho Yakuhin, Otsuka Pharmaceuticals, Intuitive Surgical Inc. Shiro Tanaka has received lecture fee from MSD K.K. and Datack. He has received consultation fee and outsourcing fee from Daiichi Sankyo Company, Limited, Janssen Pharmaceutical K.K., and Public Health Research Foundation. He has received a research grant from Novo Nordisk. De Moor Raf, Li Nan, and Hirozane Mariko are employees of Janssen Pharmaceutical K.K. Wu David Bin-Chia, Hong Li Wen, and Yu Dae Young are employees of Janssen Pharmaceutical Companies of Johnson and Johnson Asia Pacific Regional Office Singapore. Mahmoud Hashim is an employee of Janssen Vaccines & Prevention B.V. in the Netherlands. De Moor Raf, Li Nan, and Hirozane Mariko have stock or stock options of Johnson & Johnson. Brian Hutton has previously received honoraria from EVERSANA™ and Evidinno Outcomes Inc. for the provision of methodologic advice related to systematic reviews, meta-analyses, and indirect comparisons. Krista Tantakoun, Christopher Olsen, Fatemeh Mirzayeh Fashami, Imtiaz Samjoo, and Chris Cameron are employees of EVERSANA™, which was a paid consultant to Janssen Pharmaceutical K.K. in connection with the development of this manuscript; Chris Cameron is also a shareholder of EVERSANA™. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
